332 related articles for article (PubMed ID: 29290815)
1. Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization.
Lei X; Chen M; Huang M; Li X; Shi C; Zhang D; Luo L; Zhang Y; Ma N; Chen H; Liang H; Ye W; Zhang D
Theranostics; 2018; 8(2):384-398. PubMed ID: 29290815
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
3. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
4. Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.
Chen M; Lei X; Shi C; Huang M; Li X; Wu B; Li Z; Han W; Du B; Hu J; Nie Q; Mai W; Ma N; Xu N; Zhang X; Fan C; Hong A; Xia M; Luo L; Ma A; Li H; Yu Q; Chen H; Zhang D; Ye W
J Clin Invest; 2017 Oct; 127(10):3689-3701. PubMed ID: 28846068
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
6. p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin.
Chichger H; Duong H; Braza J; Harrington EO
FASEB J; 2015 Mar; 29(3):868-81. PubMed ID: 25404710
[TBL] [Abstract][Full Text] [Related]
7. Detection of Hyperacute Reactions of Desacetylvinblastine Monohydrazide in a Xenograft Model Using Intravoxel Incoherent Motion DWI and R2* Mapping.
Liang J; Ma R; Chen H; Zhang D; Ye W; Shi C; Luo L
AJR Am J Roentgenol; 2019 Apr; 212(4):717-726. PubMed ID: 30699010
[TBL] [Abstract][Full Text] [Related]
8. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin.
Liu J; Miao G; Wang B; Zheng N; Ma L; Chen X; Wang G; Zhao X; Zhang L; Zhang L
Biochem Biophys Res Commun; 2018 Mar; 497(2):742-748. PubMed ID: 29462613
[TBL] [Abstract][Full Text] [Related]
10. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin.
Setyawati MI; Tay CY; Chia SL; Goh SL; Fang W; Neo MJ; Chong HC; Tan SM; Loo SC; Ng KW; Xie JP; Ong CN; Tan NS; Leong DT
Nat Commun; 2013; 4():1673. PubMed ID: 23575677
[TBL] [Abstract][Full Text] [Related]
11. SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1.
Zhang J; Huang J; Qi T; Huang Y; Lu Y; Zhan T; Gong H; Zhu Z; Shi Y; Zhou J; Yu L; Zhang X; Cheng H; Ke Y
FASEB J; 2019 Jan; 33(1):1124-1137. PubMed ID: 30102570
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.
Menon C; Ghartey A; Canter R; Feldman M; Fraker DL
Ann Surg; 2006 Nov; 244(5):781-91. PubMed ID: 17060772
[TBL] [Abstract][Full Text] [Related]
13. Rab5-mediated VE-cadherin internalization regulates the barrier function of the lung microvascular endothelium.
Yang J; Yao W; Qian G; Wei Z; Wu G; Wang G
Cell Mol Life Sci; 2015 Dec; 72(24):4849-66. PubMed ID: 26112597
[TBL] [Abstract][Full Text] [Related]
14. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation increases the endothelial permeability and the transendothelial migration of tumor cells through ADAM10-activation and subsequent degradation of VE-cadherin.
Kouam PN; Rezniczek GA; Adamietz IA; Bühler H
BMC Cancer; 2019 Oct; 19(1):958. PubMed ID: 31619190
[TBL] [Abstract][Full Text] [Related]
16. Losartan protects against myocardial ischemia and reperfusion injury
Li Y; Yao Y; Li J; Chen Q; Zhang L; Wang QK
FASEB J; 2019 Jul; 33(7):8555-8564. PubMed ID: 30991833
[TBL] [Abstract][Full Text] [Related]
17. Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling.
Vincent L; Kermani P; Young LM; Cheng J; Zhang F; Shido K; Lam G; Bompais-Vincent H; Zhu Z; Hicklin DJ; Bohlen P; Chaplin DJ; May C; Rafii S
J Clin Invest; 2005 Nov; 115(11):2992-3006. PubMed ID: 16224539
[TBL] [Abstract][Full Text] [Related]
18. Puerarin Protects Against LPS-Induced Vascular Endothelial Cell Hyperpermeability via Preventing Downregulation of Endothelial Cadherin.
Deng HF; Wang S; Wang XL; Li L; Xie F; Zeng ZW; Zhang WX
Inflammation; 2019 Aug; 42(4):1504-1510. PubMed ID: 31102123
[TBL] [Abstract][Full Text] [Related]
19. Endothelial barrier stabilization by a cyclic tandem peptide targeting VE-cadherin transinteraction in vitro and in vivo.
Heupel WM; Efthymiadis A; Schlegel N; Müller T; Baumer Y; Baumgartner W; Drenckhahn D; Waschke J
J Cell Sci; 2009 May; 122(Pt 10):1616-25. PubMed ID: 19420236
[TBL] [Abstract][Full Text] [Related]
20. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S
J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
